NewsRx
HEALTHCARE MERGERS & ACQUISITIONS ALERT
March 6, 2006


This update is brought to you by Healthcare Mergers, Acquisitions & Ventures Week, a leading research newsletter for biotech and pharmaceutical professionals. For more information, go to Healthcare Mergers, Acquisitions & Ventures Week.


Chiron receives European Commission approval for proposed merger with Novartis

Chiron Corp. (CHIR) announced that the European Commission (EC) adopted a decision pursuant to Article 6(1)(b) of the Council Regulation (EC) No. 139/2004 declaring the combination of Chiron and Novartis compatible with the common market.

This follows approval by the U.S. Federal Trade Commission (FTC) in December 2005 and clearance by the Committee on Foreign Investment in the United States (CFIUS) under Exon-Florio in January 2006.


Save on NewsRx Timed Passes

Got a short-term project for which you need a full time database of quality clinical information? NewsRx Timed Passes let you access our database of more than 240,000 articles for a day, a week, a month or up to six months at a fraction of our site license costs. You set your limits and control your costs. You get the convenience of a site license without the long-term commitment or cost. Go to Timed Access to see how.


Subject to stockholder approval and other customary conditions, Chiron and Novartis expect that this transaction will be completed in the first half of 2006.


Save a bundle!

Need a quick and inexpensive way to view the most recent research in your field? NewsRx Bundled let's you buy 10, 25, 50 articles at discounts that range from 20% to 50% off our single article price of $3 each. Need more? You size it. Set the number of articles you want and save up to 50% over our single article costs. Go to NewsRx Bundled and we'll show you how.


Chiron Corp. and Novartis, AG, and their respective directors and officers may be deemed to be participants in the solicitation of proxies from Chiron shareholders in connection with the merger. Information about the directors and executive officers of Chiron and their ownership of Chiron's stock is set forth in the proxy statement for Chiron's 2005 annual meeting of shareholders.


Custom Reports at Discount Prices

Tired of prepackaged reports that just don't meet your needs? Build your own custom report from the NewsRx database. You control the size and the cost, while enjoying discounts that range from 20% to 50% off our regular article price. Go to Custom reports for more information.


You are receiving NewsRx Healthcare Mergers & Acquisitions Alert per your request entered at our website,
www.NewsRx.com. Please feel free to share this email with interested colleagues, but do not forward unless requested. If you are receiving this email in error, you may unsubscribe from all alerts.

NewsRx does not and will not share your email address with anyone. It is used solely for the purposes of delivering to you requested free Alerts. Privacy Policy and User Agreement

Copyright © 2006 NewsRx Inc. All Rights Reserved. Designated trademarks and brands are the property of their respective owners. NewsRx is headquartered at 2900 Paces Ferry Rd, Bldg D, Floor 2, Atlanta, GA, 30339. Phone: 770-507-7777 or 800-726-4550; Fax: 770-435-6800; Email: CustomerService@NewsRx.com.